Pfizer, Inc.
PFE
A
|
$25.325
-0.37%
15M
|
Health Technology
(0.0% 1d) (-8.0% 1m) (-36.8% 1y) (0.0% 2d) (-1.1% 3d) (-1.7% 7d) (51.73% volume)
Earnings Calendar: 2024-01-30
Market Cap: $ 143,403,858,195
http://www.pfizer.com
Sec Filling | Patents | 88300 employees
(US) Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
vaccine immunology brands injection
Drugs
Flector (Diclofenac Epolamine)FLECTOR (Diclofenac Epolamine)
add to watch list Paper trade email alert is off
Press-releases
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.11%
H: 0.38%
C: -0.04%
meeting
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
Published: 2024-04-09 (Crawled : 18:00) - prnewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.97%
H: 0.26%
C: -0.75%
for
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.73%
H: 2.49%
C: 0.11%
abrysvo disease positive risk for rsv results study
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
Published: 2024-04-08 (Crawled : 17:00) - prnewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
DOW A | $56.715 -0.19% 620K
|
Process Industries
|
| O: 0.44%
H: 0.4%
C: -0.72%
dean
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
Bluerock Value Exchange Fully Subscribes $46.5 Million Diversified Industrial Portfolio I DST
Published: 2024-03-27 (Crawled : 13:00) - prnewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
million
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
therapeutics
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.18%
H: 0.4%
C: -0.14%
pharmaceuticals
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Published: 2024-03-18 (Crawled : 21:00) - globenewswire.com
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.18%
H: 0.4%
C: -0.14%
ARVN | $34.24 2.36% 220K
|
Health Technology
|
| O: -3.22%
H: 4.58%
C: 3.23%
medical
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published: 2024-03-13 (Crawled : 11:00) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: 1.0%
H: 1.41%
C: -0.25%
disease pneumococcal children
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
HOLO | $2.86 27.68% 28M
|
XPON | $2.43 25.91% 7.2M
|
Last 48 Hours Insiders Buying
TPL P 3 | $591.39 1.1% 15K
|
Miscellaneous
|
15:00
RELL | $10.24 3.85% 36K
|
Electronic Technology
|
13:30
IZEA | $2.53 16K
|
Technology Services
|
00:00
RKT P 383 | $11.735 3.12% 640K
|
Finance
|
22:30
CTRN P 18090 | $23.035 2.97% 16K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% 44K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.07 -0.58% 840K
|
Health Technology
|
16:30
RMCF | $3.53 1.7K
|
Consumer Non-Durables
|
20:10